Jumia Technologies AG (JMIA)

Jumia Technologies experienced a significant stock price drop after an analyst downgrade from buy to sell, citing concerns about its net working capital and valuation compared to peer e-commerce companies.

All Talentz successfully hosted its first hackathon, bringing together African tech talents to develop innovative solutions in healthcare, education, and employment. Team Imago won with an AI-powered maternal healthcare ultrasound device, receiving ₦10 million and a trip to TechCrunch Disrupt 2025.

Three stocks - BioXcel Therapeutics, Telos, and Jumia - have shown significant momentum gains, with substantial price increases and strong performance in Benzinga's momentum rankings over the past week.

Jumia Technologies stock plunged 53.82% after reporting disappointing Q2 results, including a revenue decline and continued losses. The company plans to raise capital through a share offering, potentially diluting existing shareholder value.

Jumia Technologies (JMIA) closed the most recent trading day at $7.28, moving +1.39% from the previous trading session.